{
  "report_rows": [
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$7.35B vs. cons $7.276B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.95 vs. cons $2.888",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic Revenue Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~4.0% vs. cons 3.56%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Underlying Revenue Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~4% vs. cons 3.66%",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adj Operating Margin (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "reiterate H2-weighted expansion vs. cons 27.15%",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adj EPS Growth (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "reiterate solid growth vs. cons $10.37",
      "confidence": "HIGH"
    },
    {
      "kpi": "Fiduciary Interest Income (Q3 2026)",
      "prediction": "UNKNOWN",
      "answer": "guide ~$75-78M vs. UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side confirms no implicit H2 cut; modest upward EPS revisions expected",
  "day5_confidence": "MEDIUM"
}